NCT01805323View on ClinicalTrials.gov

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

CompletedOBSERVATIONAL

Enrollment

101

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

April 15, 2013

Study Completion Date

April 15, 2013

Conditions

Macular Edema

Interventions

DRUG

Dexamethasone Intravitreal Implant

Dexamethasone Intravitreal Implant (OZURDEX®) previously administered according to general clinical practice.

Trial Locations (1)

Unknown

Québec

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY